JRSIS HEALTH CARE CORPORATION Stock-Based Compensation
JRSIS HEALTH CARE CORPORATION (JRSS) reported Stock-Based Compensation of $245.47 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2023-11-15
- JRSIS HEALTH CARE CORPORATION share-based payment arrangement, noncash expense for the quarter ending 2023-09-30 was $81.82K, a 0.00% increase year-over-year.
- JRSIS HEALTH CARE CORPORATION share-based payment arrangement, noncash expense for the quarter ending 2023-06-30 was $81.82K.
- JRSIS HEALTH CARE CORPORATION share-based payment arrangement, noncash expense for the quarter ending 2023-03-31 was $81.82K.
- JRSIS HEALTH CARE CORPORATION share-based payment arrangement, noncash expense for the quarter ending 2022-12-31 was $81.82K.
- JRSIS HEALTH CARE CORPORATION share-based payment arrangement, noncash expense for fiscal 2022 was $245.47K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2023-09-30 | $81.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-15 | $163.64K derived: sum of 2 quarters · filed 2023-11-15 | $245.47K 10-Q · filed 2023-11-15 | $327.29K derived: sum of 4 quarters · filed 2023-11-15 |
| 2023-06-30 | $81.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | $163.64K 10-Q · filed 2023-08-21 | $245.47K derived: sum of 3 quarters · filed 2023-08-31 | $327.29K derived: sum of 4 quarters · filed 2023-11-15 |
| 2023-03-31 | $81.82K 10-Q · filed 2023-05-22 | $163.64K derived: sum of 2 quarters · filed 2023-08-31 | $245.46K derived: sum of 3 quarters · filed 2023-11-15 | |
| 2022-12-31 | $81.82K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-08-31 | $163.64K derived: sum of 2 quarters · filed 2023-11-15 | $245.47K 10-K/A · filed 2023-08-31 | |
| 2022-09-30 | $81.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-15 | $163.64K 10-Q · filed 2023-11-15 | ||
| 2022-06-30 | $81.82K 10-Q · filed 2023-08-21 |